← Leaderboards
Peter C Phillips
Children'S Hospital Of Philadelphia
$970,586
Attributed
$970,586
Total exposure
8
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,236,850 · 9
By mechanism
P01$1,509,174 · 2
U01$680,727 · 2
M01$46,949 · 5
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Gerard Thomas Berry$1,056,350
- Joel Rosenbloom$1,082,023
Others in their field
Top investigators on “Neoplasm /Cancer Chemotherapy”
- Charles A Coltman · Southwest Oncology Group$171,655,324
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Philip J Disaia · University Of California Irvine$41,530,194
- Walter J Curran · Thomas Jefferson University$37,520,030
- Samuel A Wells · Duke University$32,148,803
- Gregory H Reaman · National Childhood Cancer Foundation$19,436,422
Research focus
Neoplasm /Cancer ChemotherapyPediatric Neoplasm /CancerClinical ResearchPharmacokineticsHuman SubjectBrain NeoplasmsChild (0-11)Human Therapy EvaluationDrug Screening /EvaluationPatient Oriented ResearchClinical Trial Phase ICooperative StudyNeoplasm /Cancer PharmacologyNeoplasm /Cancer TherapyClinical TrialsAntineoplasticsNeoplasm /Cancer Relapse /RecurrenceGliomaAdolescence (12-20)Clinical Trial Phase IiDrug Administration Rate /DurationMagnetic Resonance ImagingMedulloblastomaCentral Nervous System Neoplasms
Grant awards (17)
STI-571 IN CHILDREN WITH BRAINSTEM AND INTRACRANIAL GLIOMAS$12,901
M01 · FY2005 · RR
PHASE I STUDY OF CILENGITIDE (EMD 121974) IN CHILDREN W/REFRACTORY BRAIN TUMORS$4,731
M01 · FY2005 · RR
TEMOZOLOMIDE AND O6-BENZYLGUANINE IN PEDIATRIC PATIENTS W/RECURRENT BRAIN TUMORS$2,838
M01 · FY2005 · RR
PBTC 007: A PHASE I/II TRIAL OF ZD1839 (IRESSATM) AND RADIATION$1,290
M01 · FY2005 · RR
PBTC 003: PHASE I TRIAL OF SCH 66336 IN RECURRENT BRAIN TUMORS$861
M01 · FY2005 · RR
STI-571 in children with brainstem and intracranial gliomas$9,740
M01 · FY2004 · RR
PBTC 007: A phase I/II trial of ZD1839 (IressaTM) and radiation$6,494
M01 · FY2004 · RR
Temozolomide and O6-Benzylguanine in pediatric patients w/recurrent brain tumors$4,383
M01 · FY2004 · RR
Phase I study of Cilengitide (EMD 121974) in children w/refractory brain tumors$2,783
M01 · FY2004 · RR
PBTC003: Phase I trial of SCH 66336 in recurrent brain tumors$928
M01 · FY2004 · RR
PEDIATRIC BRAIN TUMOR CONSORTIUM--CHOP MEMBERSHIP$146,999
U01 · FY2003 · CA
PEDIATRIC BRAIN TUMOR CONSORTIUM--CHOP MEMBERSHIP$140,050
U01 · FY2002 · CA
PEDIATRIC BRAIN TUMOR CONSORTIUM--CHOP MEMBERSHIP$146,430
U01 · FY2001 · CA
PRIMITIVE NEUROECTODERMAL TUMORS OF CHILDHOOD$1,266,264
P01 · FY2000 · NS
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY$242,910
P01 · FY2000 · NS
PEDIATRIC BRAIN TUMOR CONSORTIUM--CHOP MEMBERSHIP$147,320
U01 · FY2000 · CA
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$99,928
U01 · FY2000 · CA